EDMOND DE ROTHSCHILD HOLDING S.A.
Position in DNLI — Denali Therapeutics Inc.
CIK 1649647
Chambesy, V8
Position in DNLI
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$4,333,056
+$607,080 QoQ
Shares Held
225,680
0.0% QoQ
Ownership
0.142%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026EDMOND DE ROTHSCHILD HOLDING S.A. holds $85,177,335 across 13 Biotechnology names. DNLI ranks #5 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMRN |
Biomarin Pharmaceutical Inc
|
686,030 | $38,753,834 | |
| 2 | ONC |
BeOne Medicines Ltd.
|
43,430 | $12,897,407 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
137,190 | $10,301,597 | |
| 4 | BNTX |
BioNTech SE
|
92,310 | $8,204,512 | |
| 5 | DNLI |
Denali Therapeutics Inc.
This page
|
225,680 | $4,333,056 | |
| 6 | MRNA |
Moderna, Inc.
|
70,747 | $3,593,947 | |
| 7 | GERN |
Geron Corp
|
2,330,000 | $3,471,700 | |
| 8 | ARGX |
Argenx SE
|
2,173 | $1,586,833 |
All Filings in DNLI
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,333,056 | 225,680 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $3,725,976 | 225,680 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,986,473 | 205,680 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,877,463 | 205,680 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,796,219 | 205,680 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $4,191,758 | 205,680 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $5,991,458 | 205,680 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,775,889 | 205,680 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $4,220,553 | 205,680 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $3,555,492 | 165,680 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $2,060,524 | 99,880 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,947,458 | 99,880 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $2,301,235 | 99,880 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $2,777,662 | 99,880 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $3,065,317 | 99,880 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $2,939,468 | 99,880 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $3,213,139 | 99,880 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $4,454,648 | 99,880 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $5,045,000 | 100,000 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $6,055,568 | 77,200 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $3,254,700 | 57,000 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,256,400 | 15,000 | Shares | Sole | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||